Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients - the randomized, EU-wide, placebo-controlled, phase II study design of IXION
FX06预防住院非插管COVID-19患者疾病进展的潜力——IXION公司开展的随机、欧盟范围、安慰剂对照II期研究
期刊:Trials
影响因子:2
doi:10.1186/s13063-022-06609-x
Kloka, Jan; Friedrichson, Benjamin; Dauth, Stephanie; Foldenauer, Ann Christina; Bulczak-Schadendorf, Anita; Vehreschild, Maria J G T; Matos, Francisco Maio; Riera-Mestre, Antoni; van Asselt, Antoinette D I; De Robertis, Edoardo; Juskeviciene, Vilma Traskaite; Meybohm, Patrick; Tomescu, Dana; Lacombe, Karine; Stehouwer, Coen D A; Zacharowski, Kai